Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PSIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
UBE2V2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HP1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIVEP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF3F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTPBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM35A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM117B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RCOR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FERMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCLK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on